SCHEMBL3343791

SCHEMBL3343791

Cc1ccc(-c2ccn(CCO)n2)cc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP11B1 P15538 1/20 0.40
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
NPC1 O15118 3/20 0.38
KEAP1 Q14145 1/20 0.38
RAB9A P51151 3/20 0.37
NR5A2 O00482 2/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PIK3CD O00329 1/20 0.35
PIP5K1C O60331 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PI4KA P42356 1/20 0.35
PIK3CG P48736 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343786 0.81 MKNK1 (0.39) SMN1; SMN2ALDH1A1KMT2AMEN1NPC1
SCHEMBL2614654 0.80 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1KDM4ECYP11B1KMT2A
SCHEMBL3346678 0.80 KEAP1 (0.59) SMN1; SMN2ALDH1A1KDM4ECYP11B1KMT2A
SCHEMBL3343246 0.80 MEN1 (0.48) SMN1; SMN2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL20442664 0.79 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL3342753 0.75 HDAC3 (0.44) SMN1; SMN2ALDH1A1KDM4ECYP11B1RAB9A
SCHEMBL3343074 0.74 GAA (0.42) SMN1; SMN2ALDH1A1KDM4ECYP11B1RAB9A
SCHEMBL5346265 0.72 KMT2A (0.56) SMN1; SMN2ALDH1A1KDM4EKMT2AMEN1
SCHEMBL9384038 0.72 KMT2A (0.55) SMN1; SMN2ALDH1A1KDM4EKMT2ANPC1
SCHEMBL4128219 0.70 DYRK1A (0.41) KMT2APIK3CDPIK3CBPIK3CGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 SMN1; SMN2 2819/4885ALDH1A1 1506/4885KDM4E 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.